Oral tolerance, an active immunologic process mediated by multiple mechanisms.
about
Nutritional Keys for Intestinal Barrier Modulation2011 Update: antigen-specific therapy in type 1 diabetesFood for thought: can immunological tolerance be induced to treat asthma?CD40L in autoimmunity and mucosally induced tolerance.Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?Allergy and the gastrointestinal system.CD4+ CD25+ regulatory T cells modulate the T-cell and antibody responses in helicobacter-infected BALB/c mice.Immune intervention in type 1 diabetes.Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells.Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection.Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiationOral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.Oral Administration of Shark Type II Collagen Suppresses Complete Freund's Adjuvant-Induced Rheumatoid Arthritis in Rats.Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?Induction of immune tolerance in the treatment of rheumatoid arthritis.Immunological mechanisms for desensitization and tolerance in food allergy.Exposure of immunologically naive laboratory rodents to antigen via the airways. Where does tolerance stop and sensitization begin?Heated allergens and induction of tolerance in food allergic children.Edible plants for oral delivery of biopharmaceuticals.Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis.The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.Oral administration of bovine whey proteins to mice elicits opposing immunoregulatory responses and is adjuvant dependent.Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.Immune Modulation and Prevention of Autoimmune Disease by Repeated Sequences from Parasites Linked to Self Antigens.Allergen-specific immunosuppression by mucosal treatment with recombinant Ves v 5, a major allergen of Vespula vulgaris venom, in a murine model of wasp venom allergy.
P2860
Q26772345-4585DD75-04B3-4ECC-AF8A-148695D7E95EQ33593629-E7980367-C7DE-4B87-A632-62BE511B002DQ34249844-2503CD7E-25F1-437F-80F2-58D428F0D986Q34502868-9FB91D22-ADCE-4AD4-8338-056A84DB52EDQ34567725-C6A7794F-3F90-43FD-B45E-4346F288B85BQ34595969-6305F13F-F8E0-4F44-AD06-53D338A87344Q34681157-FE762FEE-391C-47EE-96A2-C19156EDDB92Q35226251-F21FFA8D-26C1-42C7-87B4-C20F7A34B11BQ35589934-23A802E8-CC1E-4681-9867-6D3FFB1C6E1BQ35668744-6478DC17-7CA4-4D4C-AF35-FC7DDF77714DQ35769939-DAD89550-E04A-4A83-99BF-1209D0410366Q35861182-8F7CF559-814D-4280-9A84-75243F040AEDQ36229469-9341A08B-1A81-4782-9164-40654C58F263Q36884163-E7611678-E551-4EC9-BD1A-E0CBD35BCE80Q37069755-B03F3AE3-51FD-4B1E-BE8E-5D818B132680Q37148727-53E558D8-7F2F-4398-9527-46BF9C297A89Q37516558-E93866BE-FB63-40BA-8FFA-3B68DF0C3176Q37862081-B3A20C19-A7E4-4187-B459-7DDBE6A1AD7CQ38028369-B1EAEA04-561E-4202-92AA-B266D50D6B80Q38056181-5C015DDE-A9E3-4BD8-B928-FFF9FADBD778Q38112250-B2CDF484-FCC9-4305-BE9E-E7CC2D5E5B7CQ38796221-0BF318DC-6725-4CF3-BF34-89A8DC1B88FBQ43078165-DCC8FA46-B164-471F-915B-A4B8C27F64FEQ44461538-0A2A085D-8D14-4FE5-8492-A42B39FF8683Q46201135-2F09B067-B080-45FE-BD3B-E74626B07F01Q47927308-81CE86A7-6C1D-495E-A5AD-468A9D172DC0Q50850898-6058EE7F-8C11-43C3-A789-27A4BF28844EQ51574850-968E759A-4395-4F4A-AAE2-59815B1E3C8EQ52641734-C6FD323B-7D4F-4BC2-A67A-59A42110C086
P2860
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
@ast
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
@en
type
label
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
@ast
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
@en
prefLabel
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
@ast
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
@en
P2860
P356
P1476
Oral tolerance, an active immunologic process mediated by multiple mechanisms.
@en
P2093
H L Weiner
P2860
P304
P356
10.1172/JCI11348
P407
P577
2000-10-01T00:00:00Z